[Hereditary angioedema--treatment].
Hereditary angioedema (HAE) is an autosomal-dominant condition, characterized by episodic recurrent attacks of angioedema, which can be occasionally life-threatening. Therapy for HAE consists of three points: treatment of acute attacks and both short- and long-term prophylaxis. Authors describe the methods which should be performed during the attacks of angioedema and drugs for those situations. Besides we describe the main rules of prophylaxis including potentially triggering events. Finally authors present future therapeutic options including new drugs being in clinical trial at present. In the near future, such drugs will be available to provide more effective treatment for HAE attacks with fewer adverse effects than the currently available treatment options.
Department of Family Medicine, Medical University of Wrocław, Poland.
Agnieszka
A
Muszyńska
Andrzej M
AM
Fal
D000328:Adult; D054179:Angioedemas, Hereditary / Q000628:therapy*; D001920:Bradykinin / Q000031:analogs & derivatives / Q000627:therapeutic use; D065168:Bradykinin Receptor Antagonists; D050718:Complement C1 Inhibitor Protein / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors; D008297:Male; D011322:Primary Prevention / Q000379:methods; D011994:Recombinant Proteins / Q000627:therapeutic use
D065168:Bradykinin Receptor Antagonists; D050718:Complement C1 Inhibitor Protein; D011994:Recombinant Proteins; C065679:icatibant; D007610:Kallikreins; D001920:Bradykinin
Dziedziczny obrzek naczynioruchowy--leczenie.